185 related articles for article (PubMed ID: 29203643)
1. The N-Terminal CCHC Zinc Finger Motif Mediates Homodimerization of Transcription Factor BCL11B.
Grabarczyk P; Winkler P; Delin M; Sappa PK; Bekeschus S; Hildebrandt P; Przybylski GK; Völker U; Hammer E; Schmidt CA
Mol Cell Biol; 2018 Mar; 38(5):. PubMed ID: 29203643
[TBL] [Abstract][Full Text] [Related]
2. Unveiling the N-Terminal Homodimerization of BCL11B by Hybrid Solvent Replica-Exchange Simulations.
Schulig L; Grabarczyk P; Geist N; Delin M; Forkel H; Kulke M; Delcea M; Schmidt CA; Link A
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33807484
[TBL] [Abstract][Full Text] [Related]
3. Easy Expression and Purification of Fluorescent N-Terminal BCL11B CCHC Zinc Finger Domain.
Susemihl A; Nagel F; Grabarczyk P; Schmidt CA; Delcea M
Molecules; 2021 Dec; 26(24):. PubMed ID: 34946663
[TBL] [Abstract][Full Text] [Related]
4. BCL11B mutations in patients affected by a neurodevelopmental disorder with reduced type 2 innate lymphoid cells.
Lessel D; Gehbauer C; Bramswig NC; Schluth-Bolard C; Venkataramanappa S; van Gassen KLI; Hempel M; Haack TB; Baresic A; Genetti CA; Funari MFA; Lessel I; Kuhlmann L; Simon R; Liu P; Denecke J; Kuechler A; de Kruijff I; Shoukier M; Lek M; Mullen T; Lüdecke HJ; Lerario AM; Kobbe R; Krieger T; Demeer B; Lebrun M; Keren B; Nava C; Buratti J; Afenjar A; Shinawi M; Guillen Sacoto MJ; Gauthier J; Hamdan FF; Laberge AM; Campeau PM; Louie RJ; Cathey SS; Prinz I; Jorge AAL; Terhal PA; Lenhard B; Wieczorek D; Strom TM; Agrawal PB; Britsch S; Tolosa E; Kubisch C
Brain; 2018 Aug; 141(8):2299-2311. PubMed ID: 29985992
[TBL] [Abstract][Full Text] [Related]
5. Multisystem Anomalies in Severe Combined Immunodeficiency with Mutant BCL11B.
Punwani D; Zhang Y; Yu J; Cowan MJ; Rana S; Kwan A; Adhikari AN; Lizama CO; Mendelsohn BA; Fahl SP; Chellappan A; Srinivasan R; Brenner SE; Wiest DL; Puck JM
N Engl J Med; 2016 Dec; 375(22):2165-2176. PubMed ID: 27959755
[TBL] [Abstract][Full Text] [Related]
6. The BCL11B tumor suppressor is mutated across the major molecular subtypes of T-cell acute lymphoblastic leukemia.
Gutierrez A; Kentsis A; Sanda T; Holmfeldt L; Chen SC; Zhang J; Protopopov A; Chin L; Dahlberg SE; Neuberg DS; Silverman LB; Winter SS; Hunger SP; Sallan SE; Zha S; Alt FW; Downing JR; Mullighan CG; Look AT
Blood; 2011 Oct; 118(15):4169-73. PubMed ID: 21878675
[TBL] [Abstract][Full Text] [Related]
7. BCL11B functionally associates with the NuRD complex in T lymphocytes to repress targeted promoter.
Cismasiu VB; Adamo K; Gecewicz J; Duque J; Lin Q; Avram D
Oncogene; 2005 Oct; 24(45):6753-64. PubMed ID: 16091750
[TBL] [Abstract][Full Text] [Related]
8. Bcl11b mutations identified in murine lymphomas increase the proliferation rate of hematopoietic progenitor cells.
Karlsson A; Nordigården A; Jönsson JI; Söderkvist P
BMC Cancer; 2007 Oct; 7():195. PubMed ID: 17941976
[TBL] [Abstract][Full Text] [Related]
9. A de novo substitution in BCL11B leads to loss of interaction with transcriptional complexes and craniosynostosis.
Goos JAC; Vogel WK; Mlcochova H; Millard CJ; Esfandiari E; Selman WH; Calpena E; Koelling N; Carpenter EL; Swagemakers SMA; van der Spek PJ; Filtz TM; Schwabe JWR; Iwaniec UT; Mathijssen IMJ; Leid M; Twigg SRF
Hum Mol Genet; 2019 Aug; 28(15):2501-2513. PubMed ID: 31067316
[TBL] [Abstract][Full Text] [Related]
10. Transcription Factor Bcl11b Controls Identity and Function of Mature Type 2 Innate Lymphoid Cells.
Califano D; Cho JJ; Uddin MN; Lorentsen KJ; Yang Q; Bhandoola A; Li H; Avram D
Immunity; 2015 Aug; 43(2):354-68. PubMed ID: 26231117
[TBL] [Abstract][Full Text] [Related]
11. A Bcl11b
Matsumoto K; Okuyama K; Sidwell T; Yamashita M; Endo T; Satoh-Takayama N; Ohno H; Morio T; Rothenberg EV; Taniuchi I
Front Immunol; 2024; 15():1363704. PubMed ID: 38495886
[TBL] [Abstract][Full Text] [Related]
12. Nuclear import of BCL11B is mediated by a classical nuclear localization signal and not the Krüppel-like zinc fingers.
Grabarczyk P; Delin M; Rogińska D; Schulig L; Forkel H; Depke M; Link A; Machaliński B; Schmidt CA
J Cell Sci; 2021 Dec; 134(23):. PubMed ID: 34714335
[TBL] [Abstract][Full Text] [Related]
13. ZNF652, a novel zinc finger protein, interacts with the putative breast tumor suppressor CBFA2T3 to repress transcription.
Kumar R; Manning J; Spendlove HE; Kremmidiotis G; McKirdy R; Lee J; Millband DN; Cheney KM; Stampfer MR; Dwivedi PP; Morris HA; Callen DF
Mol Cancer Res; 2006 Sep; 4(9):655-65. PubMed ID: 16966434
[TBL] [Abstract][Full Text] [Related]
14. Depletion of B cell CLL/Lymphoma 11B Gene Expression Represses Glioma Cell Growth.
Liao CK; Fang KM; Chai K; Wu CH; Ho CH; Yang CS; Tzeng SF
Mol Neurobiol; 2016 Aug; 53(6):3528-3539. PubMed ID: 26096706
[TBL] [Abstract][Full Text] [Related]
15. BCL11B enhances TCR/CD28-triggered NF-kappaB activation through up-regulation of Cot kinase gene expression in T-lymphocytes.
Cismasiu VB; Duque J; Paskaleva E; Califano D; Ghanta S; Young HA; Avram D
Biochem J; 2009 Jan; 417(2):457-66. PubMed ID: 18831712
[TBL] [Abstract][Full Text] [Related]
16. Proteome analysis reveals new mechanisms of Bcl11b-loss driven apoptosis.
Karanam NK; Grabarczyk P; Hammer E; Scharf C; Venz S; Gesell-Salazar M; Barthlen W; Przybylski GK; Schmidt CA; Völker U
J Proteome Res; 2010 Aug; 9(8):3799-811. PubMed ID: 20513151
[TBL] [Abstract][Full Text] [Related]
17. Zinc finger-mediated protein interactions modulate Ikaros activity, a molecular control of lymphocyte development.
Sun L; Liu A; Georgopoulos K
EMBO J; 1996 Oct; 15(19):5358-69. PubMed ID: 8895580
[TBL] [Abstract][Full Text] [Related]
18. Coordinated regulation of transcription factor Bcl11b activity in thymocytes by the mitogen-activated protein kinase (MAPK) pathways and protein sumoylation.
Zhang LJ; Vogel WK; Liu X; Topark-Ngarm A; Arbogast BL; Maier CS; Filtz TM; Leid M
J Biol Chem; 2012 Aug; 287(32):26971-88. PubMed ID: 22700985
[TBL] [Abstract][Full Text] [Related]
19. Reconstitution of the KRAB-KAP-1 repressor complex: a model system for defining the molecular anatomy of RING-B box-coiled-coil domain-mediated protein-protein interactions.
Peng H; Begg GE; Schultz DC; Friedman JR; Jensen DE; Speicher DW; Rauscher FJ
J Mol Biol; 2000 Feb; 295(5):1139-62. PubMed ID: 10653693
[TBL] [Abstract][Full Text] [Related]
20. BCL11B tumor suppressor inhibits HDM2 expression in a p53-dependent manner.
Obata M; Kominami R; Mishima Y
Cell Signal; 2012 May; 24(5):1047-52. PubMed ID: 22245141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
